Cassava Sciences(US:SAVA) Seeking Alphaยท2025-09-25 14:26Group 1 - The article discusses the recent failure of Cassava Sciences' drug program for Alzheimer's disease and the company's decision to move away from this area of research [1] - The author emphasizes a focus on growth markets, particularly in AI and biotech, while also exploring undervalued stocks with significant potential [1] - The investment strategy is influenced by Warren Buffett's principles but applied to riskier investments, with a portfolio that spans from megacap to microcap stocks [1] Group 2 - The author has been investing since 2021 and has a vast network for sharing insights, focusing primarily on the U.S. market but occasionally considering European or Canadian stocks [1] - The investment portfolio includes sectors such as semiconductor, mining, and biotech, with a particular interest in companies that are under-the-radar [1] - The author holds a Master's Degree in Law and serves as the deputy director general in a leading European sector organization [1]